Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Biochem J
2002 Oct 01;367Pt 1:239-46. doi: 10.1042/BJ20020841.
Show Gene links
Show Anatomy links
Transport of a neurotoxicant by molecular mimicry: the methylmercury-L-cysteine complex is a substrate for human L-type large neutral amino acid transporter (LAT) 1 and LAT2.
Simmons-Willis TA
,
Koh AS
,
Clarkson TW
,
Ballatori N
.
???displayArticle.abstract???
Methylmercury (MeHg) readily crosses cell membrane barriers to reach its target tissue, the brain. Although it is generally assumed that this rapid transport is due to simple diffusion, recent studies have demonstrated that MeHg is transported as a hydrophilic complex, and possibly as an L-cysteine complex on the ubiquitous L-type large neutral amino acid transporters (LATs). To test this hypothesis, studies were carried out in Xenopus laevis oocytes expressing two of the major L-type carriers in humans, LAT1-4F2 heavy chain (4F2hc) and LAT2-4F2hc. Oocytes expressing LAT1-4F2hc or LAT2-4F2hc demonstrated enhanced uptake of [(14)C]MeHg when administered as the L-cysteine or D,L-homocysteine complexes, but not when administered as the D-cysteine, N -acetyl-L-cysteine, penicillamine or GSH complexes. Kinetic analysis of transport indicated that the apparent affinities ( K (m)) of MeHg-L-cysteine uptake by LAT1 and LAT2 (98+/-8 and 64+/-8 microM respectively) were comparable with those for methionine (99+/-9 and 161+/-11 microM), whereas the V (max) values were higher for MeHg-L-cysteine, indicating that it may be a better substrate than the endogenous amino acid. Uptake and efflux of [(3)H]methionine and [(14)C]MeHg-L-cysteine were trans -stimulated by leucine and phenylalanine, but not by glutamate, indicating that MeHg-L-cysteine is both a cis - and trans -substrate. In addition, [(3)H]methionine efflux was trans -stimulated by leucine and phenylalanine even in the presence of an inwardly directed methionine gradient, demonstrating concentrative transport by both LAT1 and LAT2. The present results describe a major molecular mechanism by which MeHg is transported across cell membranes and indicate that metal complexes may form a novel class of substrates for amino acid carriers. These transport proteins may therefore participate in metal ion homoeostasis and toxicity.
Ballatori,
Impaired biliary excretion and whole body elimination of methylmercury in rats with congenital defect in biliary glutathione excretion.
1995, Pubmed
Ballatori,
Impaired biliary excretion and whole body elimination of methylmercury in rats with congenital defect in biliary glutathione excretion.
1995,
Pubmed
Ballatori,
Developmental changes in the biliary excretion of methylmercury and glutathione.
1982,
Pubmed
Boado,
Selective expression of the large neutral amino acid transporter at the blood-brain barrier.
1999,
Pubmed
,
Xenbase
Chillarón,
Heteromeric amino acid transporters: biochemistry, genetics, and physiology.
2001,
Pubmed
Clarkson,
The pharmacology of mercury compounds.
1972,
Pubmed
Clarkson,
Mercury in fish.
1998,
Pubmed
Clarkson,
The three modern faces of mercury.
2002,
Pubmed
Duelli,
Expression of large amino acid transporter LAT1 in rat brain endothelium.
2000,
Pubmed
Goldin,
Maintenance of Xenopus laevis and oocyte injection.
1992,
Pubmed
,
Xenbase
HUGHES,
A physicochemical rationale for the biological activity of mercury and its compounds.
1957,
Pubmed
Kageyama,
Distribution of the 4F2 light chain, LAT1, in the mouse brain.
2000,
Pubmed
Kajiwara,
Methylmercury transport across the placenta via neutral amino acid carrier.
1996,
Pubmed
Kanai,
Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98).
1998,
Pubmed
,
Xenbase
Kanai,
Heterodimeric amino acid transporters: molecular biology and pathological and pharmacological relevance.
2001,
Pubmed
Kerper,
Methylmercury transport across the blood-brain barrier by an amino acid carrier.
1992,
Pubmed
Kido,
Molecular and functional identification of large neutral amino acid transporters LAT1 and LAT2 and their pharmacological relevance at the blood-brain barrier.
2001,
Pubmed
Killian,
Predominant functional activity of the large, neutral amino acid transporter (LAT1) isoform at the cerebrovasculature.
2001,
Pubmed
Leslie,
Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters.
2001,
Pubmed
Li,
Identification of glutathione as a driving force and leukotriene C4 as a substrate for oatp1, the hepatic sinusoidal organic solute transporter.
1998,
Pubmed
,
Xenbase
Mastroberardino,
Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family.
1998,
Pubmed
,
Xenbase
Matsuo,
Expression of a system L neutral amino acid transporter at the blood-brain barrier.
2000,
Pubmed
Meier,
Activation of system L heterodimeric amino acid exchangers by intracellular substrates.
2002,
Pubmed
,
Xenbase
Mokrzan,
Methylmercury-thiol uptake into cultured brain capillary endothelial cells on amino acid system L.
1995,
Pubmed
Palacín,
Molecular biology of mammalian plasma membrane amino acid transporters.
1998,
Pubmed
Pineda,
Identification of a membrane protein, LAT-2, that Co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids.
1999,
Pubmed
,
Xenbase
Rossier,
LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter of kidney and intestine.
1999,
Pubmed
,
Xenbase
Segawa,
Identification and functional characterization of a Na+-independent neutral amino acid transporter with broad substrate selectivity.
1999,
Pubmed
,
Xenbase
Taylor,
Accumulation of free amino acids in growing Xenopus laevis oocytes.
1987,
Pubmed
,
Xenbase
Verrey,
New glycoprotein-associated amino acid transporters.
1999,
Pubmed
Verrey,
Glycoprotein-associated amino acid exchangers: broadening the range of transport specificity.
2000,
Pubmed
Wang,
gamma-Glutamyl transpeptidase and l-cysteine regulate methylmercury uptake by HepG2 cells, a human hepatoma cell line.
2000,
Pubmed
Yanagida,
Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines.
2001,
Pubmed
,
Xenbase